lobbying_activities: 3044967

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3044967	c1893713-5c70-4379-9b12-10699cbe47ee	Q3	WELSH ROSE, LLC	401104285	ASSOCIATION OF AMERICAN MEDICAL COLLEGES	2023	third_quarter	MMM	Issues related to 340B drug pricing; Medicaid disproportionate share funding graduate medical education; PDUFA Reauthorization and VALID Act. H.R. 2617 (P.L.117-328), the Consolidated Appropriations Act of 2023. Site-neutral payment policy.	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2023-10-04T17:30:22-04:00